GlassScriptPhysician profile
Rebecca Olivarez
NPI 1740011451
$1,618.43
in general payments reported to CMS, 2019-2025
10 companies · $925 in 2025
The $925 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $693 · 2025: $925.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $970 · Travel and Lodging: $512 · Education: $136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $969.96 |
| Travel and Lodging | $512.48 |
| Education | $135.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $714.75 | 2024-2025 | Interstim |
| Janssen Biotech, INC. | $315.23 | 2024-2025 | Erleada, Rybrevant, Carvykti |
| Convatec INC. | $228.38 | 2024-2025 | |
| Myriad Genetic Laboratories, INC. | $117.92 | 2024-2025 | Prolaris |
| Astellas Pharma US INC | $99.99 | 2025 | |
| Astellas Pharma Global Development | $44.81 | 2025 | Xtandi |
| Teleflex LLC | $31.53 | 2024 | Urolift |
| Boston Scientific Corporation | $28.06 | 2025 | Ams 800 Artificial Urinary Sphincter |
| Endo USA, INC. | $19.23 | 2024 | Xiaflex |
| Sumitomo Pharma America, INC. | $18.53 | 2025 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Olivarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.